Doppler measurement of cardiac output during cardiopulmonary resuscitation.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 1342801)

Published in J Accid Emerg Med on November 01, 1996

Authors

D I Fodden1, A C Crosby, K S Channer

Author Affiliations

1: Royal Hallamshire Hospital, Sheffield, United Kingdom.

Articles cited by this

Closed-chest cardiac massage. JAMA (1960) 17.63

Complications of cardiac resuscitation. Chest (1987) 2.42

Active compression-decompression. A new method of cardiopulmonary resuscitation. Cardiopulmonary Resuscitation Working Group. JAMA (1992) 2.26

Cardiac output and end-tidal carbon dioxide. Crit Care Med (1985) 1.71

A comparison of interposed abdominal compression CPR and standard CPR by monitoring end-tidal PCO2. Ann Emerg Med (1989) 1.47

Simultaneous chest compression and ventilation at high airway pressure during cardiopulmonary resuscitation. Lancet (1980) 1.34

The physiology of external cardiac massage: high-impulse cardiopulmonary resuscitation. Circulation (1984) 1.16

Cardiac output during cardiopulmonary resuscitation at various compression rates and durations. Am J Physiol (1981) 1.09

Relationship of blood pressure and flow during CPR to chest compression amplitude: evidence for an effective compression threshold. Ann Emerg Med (1983) 1.03

Transcutaneous aortovelography. A new window on the circulation? Br Heart J (1976) 1.02

Monitoring of changes in cardiac output by transcutaneous aortovelography, a non-invasive Doppler technique: comparison with thermodilution. J Nucl Med Allied Sci (1981) 1.01

Stroke distance--an improved measure of cardiovascular function. Scott Med J (1989) 0.94

Effect of time on regional organ perfusion during two methods of cardiopulmonary resuscitation. Ann Emerg Med (1984) 0.87

A new approach to the noninvasive measurement of cardiac output using an annular array Doppler technique--II. Practical implementation and results. Ultrasound Med Biol (1989) 0.86

CPR with simultaneous compression and ventilation at high airway pressure in 4 animal models. Crit Care Med (1982) 0.84

Interposed abdominal compression-CPR in human subjects. Ann Emerg Med (1984) 0.82

A preliminary study of cardiopulmonary resuscitation by circumferential compression of the chest with use of a pneumatic vest. N Engl J Med (1993) 0.82

Feasibility of noninvasive physiologic monitoring in resuscitation of trauma patients in the emergency department. Crit Care Med (1989) 0.81

Cardiac output during CPR: a comparison of two methods. Crit Care Med (1981) 0.81

[Traumatic complications of indirect cardiac massage]. Soud Lek (1989) 0.78

Cardiorespiratory analysis of cardiac arrest and resuscitation. Surg Gynecol Obstet (1966) 0.78

Articles by these authors

(truncated to the top 100)

A comparison of a low-dose warfarin induction regimen with the modified Fennerty regimen in elderly inpatients. Age Ageing (2000) 3.35

Hyperkalaemic cardiac arrhythmia caused by potassium citrate mixture. Br Med J (Clin Res Ed) (1981) 3.20

Anxiety and depression in patients with chest pain referred for exercise testing. Lancet (1985) 2.85

Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms. Eur Heart J (2000) 2.85

Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol (2006) 2.46

The Hillsborough tragedy. BMJ (1991) 2.36

Managing atrial fibrillation in elderly people. BMJ (1999) 1.92

Snow shoveller's infarction. BMJ (1991) 1.74

Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: A randomized, double-blind, placebo-controlled study. Circulation (2000) 1.71

The triad of erectile dysfunction, hypogonadism and the metabolic syndrome. Int J Clin Pract (2008) 1.69

Effect of treatment of carotid artery stenosis on blood pressure: a comparison of hemodynamic disturbances after carotid endarterectomy and endovascular treatment. Stroke (2003) 1.64

Novel platelet membrane glycoprotein VI dimorphism is a risk factor for myocardial infarction. Circulation (2001) 1.61

Deciding who should have thrombolysis. BMJ (1993) 1.59

Androgens, insulin resistance and vascular disease in men. Clin Endocrinol (Oxf) (2005) 1.58

Increasing prescription of drugs for secondary prevention after myocardial infarction. BMJ (1995) 1.57

Reporting on reports--cardiological intervention in elderly patients. J R Coll Physicians Lond (1995) 1.49

Pitfalls and problems of relying on serum troponin. QJM (2005) 1.45

How important is family history in ischaemic heart disease? QJM (1997) 1.41

Unsatisfactory management of patients with myocardial infarction admitted to general medical wards. J R Coll Physicians Lond (1994) 1.40

Junior doctors and the full shift rota--psychological and hormonal changes: a comparative cross-sectional study. Clin Med (2006) 1.40

Effect of posture and drink volume on the swallowing of capsules. Br Med J (Clin Res Ed) (1982) 1.38

Overdiagnosis of infective endocarditis. Lancet (1988) 1.38

The effect of meals of differing composition on exercise tolerance in patients with angina pectoris. Eur Heart J (1996) 1.38

Tetracycline-induced oesophageal ulceration. Br Med J (Clin Res Ed) (1981) 1.37

The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes. Eur J Endocrinol (2007) 1.30

Gender differences in the vasomotor effects of different steroid hormones in rat pulmonary and coronary arteries. Horm Metab Res (2001) 1.28

Acute soft tissue injuries of the cervical spine. BMJ (1993) 1.26

Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life. Heart (2004) 1.22

Evaluation of a protocol to select patients of all ages for cardioversion from atrial fibrillation. Age Ageing (1997) 1.16

The normal range for inter-arm differences in blood pressure. Age Ageing (1999) 1.14

Drug treatment in heart failure. BMJ (1998) 1.14

Testosterone as a protective factor against atherosclerosis--immunomodulation and influence upon plaque development and stability. J Endocrinol (2003) 1.12

A new regimen for starting warfarin therapy in out-patients. Br J Clin Pharmacol (1998) 1.12

Testosterone treatment for men with chronic heart failure. Heart (2004) 1.09

A computerized prospective audit of cardiopulmonary resuscitation in the accident and emergency department. Arch Emerg Med (1986) 1.09

Changes in haemodynamic variables during transurethral resection of the prostate: comparison of general and spinal anaesthesia. Br J Anaesth (1994) 1.08

An evaluation of the effects of Tai Chi Chuan and Chi Kung training in patients with symptomatic heart failure: a randomised controlled pilot study. Postgrad Med J (2007) 1.07

Androgen receptor CAG repeat polymorphism is associated with serum testosterone levels, obesity and serum leptin in men with type 2 diabetes. Eur J Endocrinol (2008) 1.06

Erectile dysfunction is associated with low bioactive testosterone levels and visceral adiposity in men with type 2 diabetes. Int J Androl (2007) 1.05

Estimation of left ventricular end-diastolic pressure by pulsed Doppler ultrasound. Lancet (1986) 1.05

The effect of hyoscine butylbromide on the swallowing of capsules. Br J Clin Pharmacol (1983) 1.05

Improving the interpretation of electrocardiographs in an accident and emergency department. Postgrad Med J (1995) 1.03

Towards improved control of atrial fibrillation. Eur Heart J (1987) 1.03

The hospital response to the Hillsborough tragedy. Injury (1990) 1.02

Spontaneous iliopsoas haemorrhage--an unusual complication of streptokinase therapy. Postgrad Med J (1990) 0.99

Endocarditis prophylaxis: do patients remember advice and know what to do? Br Med J (Clin Res Ed) (1986) 0.99

Testosterone acts as a coronary vasodilator by a calcium antagonistic action. J Endocrinol Invest (2002) 0.98

Selective inhibition of L-type Ca2+ channels in A7r5 cells by physiological levels of testosterone. Endocrinology (2006) 0.98

Prognostic implications of qualitative assessment of left ventricular function compared to simple routine quantitative echocardiography. Heart (1997) 0.96

Choosing drugs for secondary prevention after myocardial infarction: a pragmatic approach. Postgrad Med J (1995) 0.95

Inverse relationship between serum levels of interleukin-1beta and testosterone in men with stable coronary artery disease. Horm Metab Res (2007) 0.94

Cardiovascular effects of testosterone: implications of the "male menopause"? Heart (2003) 0.92

Improved control of atrial fibrillation with combined pindolol and digoxin therapy. Eur Heart J (1989) 0.92

The hands of karate experts. Clinical and radiological findings. Br J Sports Med (1985) 0.91

Aging reduces the responsiveness of coronary arteries from male Wistar rats to the vasodilatory action of testosterone. Clin Sci (Lond) (2000) 0.89

Antipyrine absorption after delayed oesophageal capsule transit. Br J Clin Pharmacol (1984) 0.88

Testosterone acts as an efficacious vasodilator in isolated human pulmonary arteries and veins: evidence for a biphasic effect at physiological and supra-physiological concentrations. J Endocrinol Invest (2009) 0.88

Thiazides with loop diuretics for severe congestive heart failure. Lancet (1990) 0.86

A breathless triathlete. Lancet (2002) 0.86

Effect of the calcium antagonist amlodipine on the two phases of hypoxic pulmonary vasoconstriction in rat large and small isolated pulmonary arteries. J Cardiovasc Pharmacol (1995) 0.86

Platelet glycoprotein IIIa gene polymorphism and myocardial infarction. Lancet (1996) 0.85

The effect of posture at the time of administration on the central depressant effects of the new hypnotic zopiclone. Br J Clin Pharmacol (1984) 0.85

Testosterone for secondary prevention in men with ischaemic heart disease? QJM (2003) 0.84

The influence of sex hormones on pulmonary vascular reactivity: possible vasodilator therapies for the treatment of pulmonary hypertension. Curr Vasc Pharmacol (2006) 0.84

Oesophageal abnormalities in patients with chest pain. Lancet (1986) 0.84

Treatment of knee sprains: modified Robert Jones or elastic support bandage? J Accid Emerg Med (1995) 0.83

Vasodilatory action of the calcium antagonist amlodipine on large and resistance pulmonary arteries from normoxic and chronically hypoxic rats. Clin Sci (Lond) (1993) 0.83

Effect of cigarette smoking on levels of bioavailable testosterone in healthy men. Clin Sci (Lond) (2001) 0.83

The effect of size and shape of tablets on their esophageal transit. J Clin Pharmacol (1986) 0.82

The effect of formulation on oesophageal transit. J Pharm Pharmacol (1985) 0.82

Testosterone: a natural tonic for the failing heart? QJM (2000) 0.82

Testosterone and coronary heart disease: is there a link? QJM (1997) 0.82

Assessment of the value of technician reporting of electrocardiographs in an accident and emergency department. J Accid Emerg Med (1997) 0.81

Response of normoxic pulmonary arteries of the rat in the resting and contracted state to NO synthase blockade. Br J Pharmacol (1997) 0.81

Open access echocardiography. Open access to specialist opinion is preferable. BMJ (1995) 0.80

Kozak sequence polymorphism in the platelet GPIbalpha gene is not associated with risk of myocardial infarction. Blood (2000) 0.80

Acute pulmonary vasodilatory properties of amlodipine in humans with pulmonary hypertension. Heart (1996) 0.80

Monitoring patients with left ventricular failure by electrical impedance tomography. Eur J Heart Fail (1999) 0.80

The -1185 A/G and -1051 G/A dimorphisms in the von Willebrand factor gene promoter and risk of myocardial infarction. Br J Haematol (2001) 0.80

Oesophageal function in diabetes mellitus and its association with autonomic neuropathy. Diabet Med (1985) 0.79

Dyslipidaemia is associated with testosterone, oestradiol and androgen receptor CAG repeat polymorphism in men with type 2 diabetes. Clin Endocrinol (Oxf) (2011) 0.79

Testosterone does not adversely affect fibrinogen or tissue plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1) levels in 46 men with chronic stable angina. Eur J Endocrinol (2005) 0.79

An open label, randomised, crossover study comparing sotalol and atenolol in the treatment of symptomatic paroxysmal atrial fibrillation. Heart (1999) 0.79

The role of vasopressin in cardiorespiratory arrest and pulmonary hypertension. QJM (2006) 0.78

The prothrombin 20210A allele and its association with myocardial infarction. Thromb Haemost (1999) 0.78

Subcutaneous versus intravenous administration of heparin in the treatment of deep vein thrombosis; which do patients prefer? A randomized cross-over study. Postgrad Med J (1993) 0.78

Pulmonary embolism presenting with atrial fibrillation. Lancet (1993) 0.78

Translating clinical trials into practice. Lancet (1997) 0.78

Depression: the sleeping giant. Eur Heart J (2000) 0.78

Analysis of the postulated interaction between the angiotensin II sub-type 1 receptor gene A1166C polymorphism and the insertion/deletion polymorphism of the angiotensin converting enzyme gene on risk of myocardial infarction. Atherosclerosis (2001) 0.77

Integration between general and geriatric medicine: a needs related policy. J R Coll Physicians Lond (1995) 0.77

An evaluation and improvement program for inpatient anticoagulant control. Thromb Haemost (1997) 0.77

Hypoxaemia and supplemental oxygen therapy in the first 24 hours after myocardial infarction: the role of pulse oximetry. J R Coll Physicians Lond (1998) 0.77

How patients with heart failure are managed in the United Kingdom. Eur J Heart Fail (1999) 0.77

Intravenous enoximone or dobutamine for severe heart failure after acute myocardial infarction: a randomized double-blind trial. Eur Heart J (1993) 0.77

Xamoterol improves the control of chronic atrial fibrillation in elderly patients. Age Ageing (1995) 0.77

Persistent visual hallucinations secondary to chronic solvent encephalopathy: case report and review of the literature. J Neurol Neurosurg Psychiatry (1983) 0.77

The GPIa C807T dimorphism associated with platelet collagen receptor density is not a risk factor for myocardial infarction. Br J Haematol (1999) 0.77

The role of androgen receptor CAG repeat polymorphism and other factors which affect the clinical response to testosterone replacement in metabolic syndrome and type 2 diabetes: TIMES2 sub-study. Eur J Endocrinol (2013) 0.77

Effect of delayed esophageal transit on acetaminophen absorption. Clin Pharmacol Ther (1985) 0.76